Site Reliability Engineer

Pfizer is a leading research-based biopharmaceutical company. The company applies science and its global resources to deliver innovative therapies that extend and significantly improve lives. The Company develops medicines and vaccines that help when a person gets sick and prevent them from getting sick in the first place, as well as some of the world’s best-known consumer healthcare brands. Every day, the employees work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of their time.

Pfizer has also collaborated with various healthcare providers, many governments and also the local communities in order to support and expand access to reliable, real, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on the company.

Organization Structure:

The company develops, creates, and produces medicines and vaccines for a broad range of medical disciplines, including immunology, cardiology, endocrinology, oncology, and neurology. Its products include the blockbuster drug Lipitor (atorvastatin) which is used to lower LDL blood cholesterol; Lyrica (pregabalin) used for neuropathic pain and fibromyalgia; Diflucan (fluconazole), which is an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and also Celebrex (also Celebra, celecoxib), an anti-inflammatory drug.

Product Pipeline- The priority of the company is researching and developing medicines and vaccines that will benefit their patients around the world. They are committed to addressing unmet needs across a number of important therapeutic areas including, Oncology, Inflammation & Immunology, Vaccines, Internal Medicine and Rare Disease, with the goal of delivering innovative products to patients. 

Focus Areas: Driven to Discover the Cure

1. Internal Medicine
2. Inflammation & Immunology
3. Oncology
4. Rare Disease
5. Vaccines
6. Anti-Infectives

R&D Platforms:

1. Biosimilars
2. Gene Therapy
3. Medicinal Sciences
4. Precision Medicine

Product Portfolio:

1. Products as per Prescription: Few of the prescribed products-
   
   • A-METHAPRED
   • ACCUPRIL®
   • BAVENCIO
   • ACETYLCYSTEINE
   • BENEFIX®
   • ADENOSINE
   • BACITRACIN
   • ACCURETIC®
   • ADVIL® BRANDS
   • BESPONSA™ FOR INJECTION
   • ALDACTAZIDE®
   • ALAVERT®
   • ALDACTONE®
   • ALESSE 21® AND ALESSE 28® TABLETS
2. Over-the-Counter Products: Few of the over-the-counter products-
   • ADVIL® BRANDS
   • CALTRATE®
   • CHAPSTICK®
   • ALAVERT®
   • CENTRUM® BRANDS
   • ANBESOL®
   • EMERGEN C
   • DIMETAPP®
   • FIBERCON®
   • DRISTAN®

Subsidiaries:

Pfizer has many subsidiaries, few are mentioned below:

1. Hospira
2. Upjohn
3. Warner–Lambert
4. Therachon AG
5. Parke-Davis
6. Medivation
7. Anacor
8. Alacer Corp.
9. Pfizer Japan Inc
10. Pfizer UK
11. Meridian Medical Technologies, Inc
12. ViiV Healthcare
13. G.D. Searle, LLC
14. Pharmacia & Upjohn
15. King Pharmaceuticals

About Upjohn:

Upjohn is a division of Pfizer. As an organization committed to putting patients first, Pfizer has always evolved with the changing needs of the people who rely on them to create a healthier world. That’s why their newly launched business, Upjohn, leverages the strengths at the core of who they are: an entrepreneurial mindset and a sense of purpose.

Upjohn is inspired by the heritage of Pfizer, a company known for its pioneering science. It harnesses the power of almost 20 of Pfizer's most iconic established biopharmaceutical brands all over the therapeutic areas which include Psychiatry, Pain, Cardiovascular and Urology just by thinking strategically and operating nimbly. And with the addition of our U.S. Greenstone portfolio, Upjohn’s commercial model also aims to reach a more diversified set of consumers.

At a time when healthcare is increasingly defined by a growing global middle class, a focus on quality and affordability and the rise of non-communicable diseases, Upjohn combines the agility of a startup with the resources and capabilities of a Fortune 100 enterprise. As a result, they're able to both innovate and execute quickly, from activating their portfolio to improving manufacturing to advancing research and development.

Today, Upjohn is serving more than 100+ markets and also has a network of 9 dedicated manufacturing sites bringing quality and reliability. And with roots in innovation and technological ingenuity, Upjohn is poised to take our portfolio of established medicines to the next level, bringing life-changing medicines to patients around the world and trailblazing a new path for the industry.

Mergers and Acquisitions: 

• Pfizer announced a joint merger of its consumer healthcare division with GlaxoSmithKline (GSK), the UK pharma giant on December 19, 2018. GSK, the British company will maintain a controlling stake (listed at 68%).
• Pfizer Inc. was expected to merge with Allergan, Plc in the year 2016 to create the Ireland-based "Pfizer plc" in a deal that would have been worth $160 billion. However, the merger was called off in April of the same year, because of new rules from the US Treasury against tax inversions, a method of avoiding taxes by merging with a foreign company.

Corporate Social Responsibility: